Market capitalisation, EUR | 5,763.28 m |
EPS, EUR | 0.23 |
P/B ratio | 0.82 |
P/E ratio | 82.42 |
Dividend yield | 0.00% |
Revenue, EUR | 6,592.07 m |
Net income, EUR | 59.32 m |
Profit margin | 0.90% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.09% | Equity United States Health Care Biotech | 216 | 0.35% | 37 | +22.47% | A2JDYM | IE00BDZVHG35 |
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) | 0.02% | Equity World Health Care Social/Environmental | 110 | 0.18% | 224 | +16.44% | A3DSTC | IE0006FM6MI8 |
iShares Nasdaq US Biotechnology UCITS ETF | 0.09% | Equity United States Health Care Biotech | 216 | 0.35% | 498 | +22.01% | A2DWAW | IE00BYXG2H39 |
Amundi S&P Eurozone PAB Net Zero Ambition UCITS ETF Acc | 0.03% | Equity Europe Social/Environmental Climate Change | 130 | 0.20% | 1,822 | +15.28% | LYX05H | LU2195226068 |
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 0.02% | Equity World Health Care Social/Environmental | 110 | 0.18% | 20 | +16.44% | A3DSTD | IE000JKS50V3 |
Xtrackers S&P Europe ex UK UCITS ETF | 0.02% | Equity Europe | 343 | 0.09% | 611 | +13.02% | A2JCAG | IE00BGV5VM45 |
Invesco S&P World Health Care ESG UCITS ETF Acc | 0.03% | Equity World Health Care Social/Environmental | 89 | 0.18% | 2 | +18.57% | A3D3BE | IE000L4EH2K5 |
Broker | Rating | Order fee | Stock savings plans | |
---|---|---|---|---|
![]() | 0.99€ | 1000 | View offer* | |
![]() | 0.00€ | 2500 | View offer* | |
![]() | 0.00€ | 500 | View offer* | |
![]() | 0.00€ | 300 | View offer* | |
![]() | 5.90€ | - | View offer* |